Ephedra: Is It Worth the Risk?
Jan 1, 2003
Clinical Efficacy and Side Effects
Published in: Evidence Report/Technology Assessment: no. 76 (Prepared by the Southern California/RAND Evidence-based Practice Center under contract No. 290-97-0001). AHRQ Publication No. 03-E022. Agency for Healthcare Research and Quality, Rockville, MD. Feb. 2003, 475 p
Posted on RAND.org on February 01, 2003
At the direction of the funding agencies (the National Institutes of Health Office of Dietary Supplements (ODS), the National Center for Complementary and Alternative Medicine (NCCAM), and the Agency for Healthcare Research and Quality (AHRQ)), and in consultation with our Technical Expert Panel, the authors addressed research questions regarding the efficacy of herbal ephedra and ephedrine for weight loss and athletic performance through a comprehensive literature review and synthesis of evidence. They assessed the safety of these products through review of clinical trials. Meta-analysis was performed where appropriate. In addition, the authors reviewed herbal ephedra- and ephedrine-related adverse events reports on file with the U.S. Food and Drug Administration (FDA), published case reports, and reports to a manufacturer of ephedra-containing products. It is expected that the results of this review will be used to direct further research.
This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.